324
Views
18
CrossRef citations to date
0
Altmetric
Original Investigation

Low methylation rates of dopamine receptor D2 gene promoter sites in Japanese schizophrenia subjects

, , , , , , , , , & show all
Pages 449-456 | Received 02 Mar 2016, Accepted 31 May 2016, Published online: 06 Jul 2016

References

  • Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, Stone W, Glatt SJ. 2004. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet. 127B:51–59.
  • Bell JT, Pai AA, Pickrell JK, Gaffney DJ, Pique-Regi R, Degner JF, Gilad Y, Pritchard JK. 2011. DNA methylation patterns associate with genetic and gene expression variation in HapMap cell lines. Genome Biol. 12:R10.
  • Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, Sparrow D, Vokonas P, Baccarelli A. 2009. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev. 130:234–239.
  • Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, Nelson HH, Karagas MR, Padbury JF, Bueno R, et al. 2009. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 5:e1000602.
  • Davies MN, Volta M, Pidsley R, Lunnon K, Dixit A, Lovestone S, Coarfa C, Harris RA, Milosavljevic A, Troakes C, et al. 2012. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 13:R43.
  • Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F, Kalidindi S, Picchioni M, Kravariti E, Toulopoulou T, et al. 2011. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 20:4786–4796.
  • Ehrlich S, Walton E, Roffman JL, Weiss D, Puls I, Doehler N, Burghardt R, Lehmkuhl U, Hillemacher T, Muschler M, et al. 2012. Smoking, but not malnutrition, influences promoter-specific DNA methylation of the proopiomelanocortin gene in patients with and without anorexia nervosa. Can J Psychiatry. 57:168–176.
  • Fish EW, Shahrokh D, Bagot R, Caldji C, Bredy T, Szyf M, Meaney MJ. 2004. Epigenetic programming of stress responses through variations in maternal care. Ann NY Acad Sci. 1036:167–180.
  • Horvath S, Zhang Y, Langfelder P, Kahn RS, Boks MP, van Eijk K, van den Berg LH, Ophoff RA. 2012. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 13:R97.
  • Inada T. 2009. DIEPSS: a second-generation rating scale for antipsychotic-induced extrapyramidal symptoms: drug-induced extrapyramidal symptoms scale. Tokyo, Japan: Seiwa Shoten.
  • Kinnunen AK, Koenig JI, Bilbe G. 2003. Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal pole. J Neurochem. 86:736–748.
  • Kestler LP, Walker E, Vega EM. 2011. Dopamine receptors in the brains of schizophrenia patients: a meta-analysis of the findings. Behav Pharmacol. 12:355–371.
  • Kordi-Tamandani DM, Sahranavard R, Torkamanzehi A. 2013. Analysis of association between dopamine receptor genes' methylation and their expression profile with the risk of schizophrenia. Psychiatr Genet. 23:183–187.
  • Laruelle M. 1998. Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Q J Nucl Med. 42:211–221.
  • Liu L, Yuan G, Cheng Z, Zhang G, Liu X, Zhang H. 2013. Identification of the mRNA expression status of the dopamine D2 receptor and dopamine transporter in peripheral blood lymphocytes of schizophrenia patients. PLoS One. 8:e75259.
  • Llorente R, O'Shea E, Gutierrez-Lopez MD, Llorente-Berzal A, Colado MI, Viveros MP. 2010. Sex-dependent maternal deprivation effects on brain monoamine content in adolescent rats. Neurosci Lett. 479:112–117.
  • Nishioka M, Bundo M, Koike S, Takizawa R, Kakiuchi C, Araki T, Kasai K, Iwamoto K. 2013. Comprehensive DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia. J Hum Genet. 58:91–97.
  • Numata S, Ye T, Hyde TM, Guitart-Navarro X, Tao R, Wininger M, Weinberger DR, Kleinman JE, Lipska BK. 2012. DNA methylation signatures in development and aging of the human prefrontal cortex. Am J Hum Genet. 90:260–272.
  • Pai AA, Bell JT, Marioni JC, Pritchard JK, Gilad Y. 2011. A genome-wide study of DNA methylation patterns and gene expression levels in multiple human and chimpanzee tissues. PLoS Genet. 7:e1001316.
  • Rhoades HM, Overall JE. 1998. The semistructured BPRS interview and rating guide. Psychopharmacol Bull. 24:101–104.
  • Seeman P, Lee T. 1975. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science. 188:1217–1219.
  • Seeman P, Lee T, Chau-Wong M, Wong K. 1976. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:717–719.
  • Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S, Möller HJ, Dean B. 2015. Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP think tank. Int J Neuropsychopharmacol. 18:pyv042.
  • Schäfer M, Rujescu D, Giegling I, Guntermann A, Erfurth A, Bondy B, Möller HJ. 2001. Association of short-term response to haloperidol treatment with a polymorphism in the dopamine D(2) receptor gene. Am J Psychiatry. 158:802–804.
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 511:421–427.
  • Weinberger DR. 1987. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:660–669.
  • Weinberger DR, Levitt P. 2011. Neurodevelopmental origins of schizophrenia. In Weinberger DR, Harrison PJ, editors. Schizophrenia, 3rd ed. Oxford, UK: Wiley-Blackwell.
  • Wockner LF, Noble EP, Lawford BR, Young RM, Morris CP, Whitehall VL, Voisey J. 2014. Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients. Transl Psychiatry. 4:e339.
  • World Health Organization. 2008. The global burden of disease: 2004 update. Geneva, Switzerland: WHO Press.
  • Zahari Z, Teh LK, Ismail R, Razali SM. 2011. Influence of DRD2 polymorphisms on the clinical outcomes of patients with schizophrenia. Psychiatr Genet. 21:183–189.
  • Zhang AP, Yu J, Liu JX, Zhang HY, Du YY, Zhu JD, HE G, Li XW, Gu NF, Feng GY, et al. 2007. The DNA methylation profile within the 5'-regulatory region of DRD2 in discordant sib pairs with schizophrenia. Schizophr Res. 90:97–103.
  • Zvara A, Szekeres G, Janka Z, Kelemen JZ, Cimmer C, Sántha M, Puskás LG. 2005. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers. Dis Markers. 21:61–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.